Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Rating of “Moderate Buy” by Analysts

Surgery Partners, Inc. (NASDAQ:SGRY) has been given a consensus recommendation of “Moderate Buy” by the ten research firms that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $27.1111.

Several brokerages have commented on SGRY. Barclays dropped their price objective on Surgery Partners from $24.00 to $18.00 and set an “equal weight” rating on the stock in a report on Friday, November 21st. Benchmark reduced their target price on shares of Surgery Partners from $35.00 to $30.00 and set a “buy” rating on the stock in a report on Tuesday, November 11th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Surgery Partners in a report on Monday, December 29th. Cantor Fitzgerald restated an “overweight” rating and issued a $36.00 price target on shares of Surgery Partners in a report on Tuesday, October 7th. Finally, Royal Bank Of Canada decreased their target price on shares of Surgery Partners from $35.00 to $31.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 11th.

Hedge Funds Weigh In On Surgery Partners

Institutional investors and hedge funds have recently bought and sold shares of the stock. Pentwater Capital Management LP grew its holdings in Surgery Partners by 66.9% during the third quarter. Pentwater Capital Management LP now owns 11,681,000 shares of the company’s stock worth $252,777,000 after purchasing an additional 4,681,000 shares during the period. Vanguard Group Inc. increased its position in shares of Surgery Partners by 5.9% during the third quarter. Vanguard Group Inc. now owns 7,614,514 shares of the company’s stock worth $164,778,000 after acquiring an additional 424,518 shares in the last quarter. King Street Capital Management L.P. increased its position in shares of Surgery Partners by 24.5% during the 2nd quarter. King Street Capital Management L.P. now owns 6,225,000 shares of the company’s stock valued at $138,382,000 after purchasing an additional 1,225,000 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in Surgery Partners by 25.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 4,860,215 shares of the company’s stock valued at $105,177,000 after buying an additional 988,956 shares in the last quarter. Finally, UBS Group AG increased its holdings in shares of Surgery Partners by 50.6% in the third quarter. UBS Group AG now owns 3,690,922 shares of the company’s stock worth $79,872,000 after purchasing an additional 1,239,549 shares during the period.

Surgery Partners Stock Performance

NASDAQ:SGRY opened at $15.90 on Friday. The stock has a market capitalization of $2.06 billion, a P/E ratio of -11.69 and a beta of 1.91. The stock has a 50-day moving average price of $16.00 and a 200 day moving average price of $19.91. The company has a current ratio of 1.88, a quick ratio of 1.72 and a debt-to-equity ratio of 1.10. Surgery Partners has a 12-month low of $14.94 and a 12-month high of $26.16.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Monday, November 10th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 5.21%.The firm had revenue of $821.50 million during the quarter, compared to the consensus estimate of $823.55 million. During the same quarter last year, the business posted $0.19 EPS. Surgery Partners’s revenue was up 6.6% compared to the same quarter last year. Equities research analysts forecast that Surgery Partners will post 0.67 EPS for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.